EUVIMEDEUVIMED entdecken
Crossref

A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing

Hanna Helena Schalkwijk iD, Aspasia Georgala, Sarah Gillemot, Arturo Temblador, Dimitri Topalis, Sebastian Wittnebel, Graciela Andrei iD, Robert Snoeck

The Journal of Infectious Diseases · 28.11.2023 · 228 (11) · 1505-1515

DOI: 10.1093/infdis/jiad184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 24.05.2023. Verfasst von Hanna Helena Schalkwijk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Herpes Simplex, Severe Combined Immunodeficiency, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Sciensano, Research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Herpes simplex virus 1 can cause severe infections in individuals who are immunocompromised. In these patients, emergence of drug resistance mutations causes difficulties in infection management.

Methods

Seventeen herpes simplex virus 1 isolates were obtained from orofacial/anogenital lesions in a patient with leaky severe combined immunodeficiency over 7 years, before and after stem cell transplantation. Spatial/temporal evolution of drug resistance was characterized genotypically—with Sanger and next-generation sequencing of viral thymidine kinase (TK) and DNA polymerase (DP)—and phenotypically. CRISPR/Cas9 was used to introduce the novel DP Q727R mutation, and dual infection-competition assays were performed to assess viral fitness.

Results

Isolates had identical genetic backgrounds, suggesting that orofacial/anogenital infections derived from the same virus lineage. Eleven isolates proved heterogeneous TK virus populations by next-generation sequencing, undetectable by Sanger sequencing. Thirteen isolates were acyclovir resistant due to TK mutations, and the Q727R isolate additionally exhibited foscarnet/adefovir resistance. Recombinant Q727R mutant virus showed multidrug resistance and increased fitness under antiviral pressure.

Conclusions

Long-term follow-up of a patient with severe combined immunodeficiency revealed virus evolution and frequent reactivation of wild-type and TK mutant strains, mostly as heterogeneous populations. The DP Q727R resistance phenotype was confirmed with CRISPR/Cas9, a useful tool to validate novel drug resistance mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanHerpes SimplexSevere Combined ImmunodeficiencyImmunologic Deficiency SyndromesHumansAntiviral AgentsGene EditingDrug Resistance, ViralAcyclovirMutationDNA-Directed DNA PolymeraseDrug Resistance, MultipleThymidine Kinase

Stichwörter der Autor:innen

CRISPR/Cas9 precise gene editingdrug resistancehematopoietic stem cell transplantationherpes simplex virus 1viral evolution

Substanzen

Antiviral AgentsAcyclovirDNA-Directed DNA PolymeraseThymidine Kinase

Autor:innen und Institutionen

  • Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven.
  • Department of Infectious Diseases, Jules Bordet Institute, Université Libre de Bruxelles, Brussels.
  • Department of Hematology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.

ORCID-Profile: Hanna Helena Schalkwijk, Graciela Andrei

Förderung

  • Sciensano
  • Research Foundation Flanders

Zitieren

APA

Schalkwijk, H. H., Georgala, A., Gillemot, S., Temblador, A., Topalis, D., Wittnebel, S., Andrei, G., & Snoeck, R. (2023). A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing. The Journal of Infectious Diseases, 228(11), 1505-1515. https://doi.org/10.1093/infdis/jiad184

Vancouver

Schalkwijk HH, Georgala A, Gillemot S, Temblador A, Topalis D, Wittnebel S, et al. A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing. The Journal of Infectious Diseases. 2023;228(11):1505-1515. doi:10.1093/infdis/jiad184

BibTeX
@article{Schalkwijk2023,
  author = {Schalkwijk, Hanna Helena and Georgala, Aspasia and Gillemot, Sarah and Temblador, Arturo and Topalis, Dimitri and Wittnebel, Sebastian and Andrei, Graciela and Snoeck, Robert},
  title = {A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  volume = {228},
  number = {11},
  pages = {1505--1515},
  doi = {10.1093/infdis/jiad184}
}
Kostenlos starten →